Chemotherapy Compounding Labelling 
European Pharmaceutical Review
DECEMBER 5, 2022
PSMAfore, is a Phase III, open-label, multi-centre, 1:1 randomised study comparing the efficacy and safety of Pluvicto to a change in ARPI in 469 patients with PSMA–positive mCRPC. Pluvicto is an intravenous radioligand therapy that combines a ligand, a targeting compound with lutetium-177, a therapeutic radionuclide.
Pharmaceutical Technology
MARCH 23, 2023
It is also being assessed in other tumour types and along with other Incyte pipeline compounds. Zynyz monotherapy showed a 52% objective response rate (ORR) in chemotherapy-naïve patients. We continue to study the potential of Zynyz in additional tumour types and in combination with other Incyte pipeline compounds.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 17, 2022
Radioligand therapy (RLT), which combines a targeting compound (ligand) with a therapeutic radioactive atom (radioisotope), is an emerging treatment approach that may offer an alternative treatment option for some cancer patients. Its licensing makes it the first diagnostic PSMA imaging tracer to receive this status in Great Britain.
European Pharmaceutical Review
OCTOBER 19, 2023
With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use. How do you perceive radiopharmaceuticals complementing existing cancer treatments, such as chemotherapy and immunotherapy? What do you envision the future of radiopharmaceuticals to be like?
The Checkup by Singlecare
MARCH 25, 2024
In human patients, it’s used to treat vomiting and nausea due to cancer chemotherapy or radiation therapy. Veterinarians commonly use ondansetron for chemotherapy, but its use in dogs is “ off-label.” Nausea-inducing chemotherapy is a common reason veterinarians give dogs ondansetron. Can dogs overdose on ondansetron?
The Checkup by Singlecare
AUGUST 15, 2024
Ondansetron for cats is an extra-label use of the drug. The most common reasons ondansetron is needed in cats are chemotherapy, drug treatment, and pancreatitis (inflamed pancreas). Chemotherapy and drug-induced vomiting Like dogs and humans, cats can get malignant cancers that require chemotherapy.
pharmaphorum
APRIL 20, 2021
One of the filings is to convert the ADC’s current conditional approval as a later-line therapy for urothelial cancer in patients previously treated with PD-1/L1 checkpoint inhibitors and platinum-based chemotherapy into a full approval. Both have been granted an FDA priority review with an action date of 17 August.
Expert insights. Personalized for you.
105 
Let's personalize your content